Eye Care
New Dorzolamide Hydrochloride Ophthalmic Solution Receives FDA Approval
New Dorzolamide Hydrochloride Ophthalmic Solution Receives FDA Approval
Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).
 
Read More >>
Evaluating Efficacy of Permethrin Cream for Demodex Blepharitis
New Contact Lenses Launched for Astigmatism and Presbyopia
Topical Insulin May Provide Relief to Patients with Diabetes and Dry Eyes
Drug's Use Broadened to Include First-Line Treatment for Involuntary Blinking
FDA Officials OK Aflibercept for Diabetic Retinopathy
Monday Pharmaceutical Mystery: May 13
Generic Treatment for Ocular Itching Approved by the FDA
View more articles >>
Clinical Trials
IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient
Interest in Electronic Applications for Patients With Glaucoma
Improve Glaucoma Medication Adherence
Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects
Investigating the Genetic Basis of Pseudoexfoliation Syndrome and Angle-closure Glaucoma
Multimedia: Videos
Encouraging Collaboration Between Pharmacy and Optometry Students
Encouraging Collaboration Between Pharmacy and Optometry Students
The Role of a Pharmacist in Caring for Ophthalmic Conditions
The Role of a Pharmacist in Caring for Ophthalmic Conditions
Interprofessional Learning for Treating Ophthalmic Conditions
Interprofessional Learning for Treating Ophthalmic Conditions
Research to Cure Vision and Brain Disorders
Research to Cure Vision and Brain Disorders